These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 15855163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C, Michalopoulos GK, Wu T.
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.
    Buchanan FG, Wang D, Bargiacchi F, DuBois RN.
    J Biol Chem; 2003 Sep 12; 278(37):35451-7. PubMed ID: 12824187
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells.
    Sun B, Rong R, Jiang H, Zhang H, Wang Y, Bai X, Zhang M, Ma J, Xia S, Shu W, Zhang L, Leng J.
    Mol Cell Biochem; 2013 Jun 12; 378(1-2):195-203. PubMed ID: 23494562
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling.
    Zhang L, Jiang L, Sun Q, Peng T, Lou K, Liu N, Leng J.
    Mol Cell Biochem; 2007 Nov 12; 305(1-2):19-26. PubMed ID: 17551669
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.
    Xu L, Han C, Wu T.
    J Biol Chem; 2006 Nov 10; 281(45):33982-96. PubMed ID: 16966336
    [Abstract] [Full Text] [Related]

  • 8. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O, Mutungi G, Beales IL.
    Endocrinology; 2006 Sep 10; 147(9):4505-16. PubMed ID: 16740977
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.
    Brochhausen C, Neuland P, Kirkpatrick CJ, Nüsing RM, Klaus G.
    Arthritis Res Ther; 2006 Sep 10; 8(3):R78. PubMed ID: 16646980
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition.
    Han C, Demetris AJ, Liu Y, Shelhamer JH, Wu T.
    J Biol Chem; 2004 Oct 22; 279(43):44344-54. PubMed ID: 15294900
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor.
    Du M, Shi F, Zhang H, Xia S, Zhang M, Ma J, Bai X, Zhang L, Wang Y, Cheng S, Yang Q, Leng J.
    Oncol Rep; 2015 Aug 22; 34(2):715-26. PubMed ID: 26058972
    [Abstract] [Full Text] [Related]

  • 12. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
    Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML.
    Cancer Res; 2004 Jan 15; 64(2):554-64. PubMed ID: 14744769
    [Abstract] [Full Text] [Related]

  • 14. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
    Wu T, Leng J, Han C, Demetris AJ.
    Mol Cancer Ther; 2004 Mar 15; 3(3):299-307. PubMed ID: 15026550
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K, Iwasaki K, Shitashige M, Endo H, Kondo H, Ishikawa I.
    J Dent Res; 2000 Dec 15; 79(12):1955-61. PubMed ID: 11201045
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM, Jiang H, Ding JX, Peng T, Ma J, Wang YH, Zhang L, Zhang H, Leng J.
    Life Sci; 2010 Jan 30; 86(5-6):214-23. PubMed ID: 20035770
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.
    Tveteraas IH, Müller KM, Aasrum M, Ødegård J, Dajani O, Guren T, Sandnes D, Christoffersen T.
    J Exp Clin Cancer Res; 2012 Sep 11; 31(1):72. PubMed ID: 22967907
    [Abstract] [Full Text] [Related]

  • 19. EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways.
    Donnini S, Finetti F, Solito R, Terzuoli E, Sacchetti A, Morbidelli L, Patrignani P, Ziche M.
    FASEB J; 2007 Aug 11; 21(10):2418-30. PubMed ID: 17384145
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM.
    Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.